Eurasian Academy of Medicine and Dentistry Eurasian Academy of Medicine and Dentistry

Search

Search results:
Fundamental Mechanisms by Which Policosanol Acts in Plant and Animal Cells
Policosanol is a valuable compound with potential applications across multiple sectors. Within the pharmaceutical field, policosanol and its main components—triacontanol, octacosanol, and hexacosanol—have shown biological activity, particularly in conditions associated with inflammation and hypercholesterolaemia. Triacontanol, specifically, serves as a plant growth promoter and is widely applied in numerous economically significant crops and microalgae, either as a pure compound or as part of policosanol extracts. This review compiles key studies addressing the bioactivity of policosanol in both plant and animal cells, enabling comparison of the different mechanisms of action. A detailed evaluation of this information opens avenues for further research. Articles were sourced from PubMed and Redalyc using specific key terms: policosanol, inflammatory mechanisms, triacontanol, cellular absorption, photosynthesis, and photoinhibition. Policosanol has been found to interfere with inflammation-related pathways, notably the NF-κB and MAPK signaling cascades. Its cholesterol-lowering capacity results from the suppression of hepatic cholesterol synthesis through the indirect inhibition of HMG-CoA reductase. Triacontanol enhances plant growth and influences biochemical and physiological traits, especially under stress, mainly by improving photosynthetic efficiency. Notably, octacosanol can suppress the activity of triacontanol in plants—a phenomenon not observed in human cells—highlighting key distinctions in how these compounds function in plant versus animal systems, which warrants further investigation.
Journal of Applied Pharmaceutical Technologies and Systems
Review | Open access | 10 July 2022 | Article: 10

Primary Care Strategies for Treating Gout: A Literature Review
Gout disease is recognized as one of the most prevalent forms of arthritis worldwide, with an estimated prevalence of around 2.5%. Its pathophysiology is primarily linked to elevated levels of uric acid in the bloodstream, which may result from either increased production or reduced renal excretion. Clinically, it often presents as a swollen, erythematous, and painful joint. The definitive method for diagnosis remains synovial aspiration from the affected joint. While acute attacks typically require management in the emergency department, long-term care is generally provided in primary care settings.This literature review aims to explore gout disease in terms of its clinical features, diagnostic approaches, and treatment strategies, particularly focusing on the role of primary care. A comprehensive search was conducted on the PubMed database using the MeSH term “gout disease” to identify pertinent studies. Gout disease continues to be among the most widespread rheumatologic conditions globally, and unhealthy lifestyle choices, including alcohol intake and high consumption of red and white meats, may exacerbate its incidence. Diagnosis may involve blood tests, radiographic imaging, and joint aspiration. Maintenance therapy, often administered in primary care, includes the use of Allopurinol or other urate-lowering agents.
Journal of Applied Pharmaceutical Technologies and Systems
Review | Open access | 10 July 2022 | Article: 13

Digoxin Toxicity in Patients with Atrial Fibrillation and Congestive Heart Failure: A Systematic Review of Clinical Manifestations
Digoxin, a cardiac glycoside, is commonly prescribed for the management of congestive heart failure, atrial fibrillation or flutter, and certain cardiac arrhythmias. However, its clinical use is limited by its narrow therapeutic index, which predisposes patients to toxicity. At elevated concentrations, digoxin toxicity can present with gastrointestinal disturbances, visual changes, and cardiac arrhythmias. This systematic review aims to summarize reported cases of digoxin toxicity, focusing on associated risk factors, drug-drug interactions, and clinical manifestations. A comprehensive literature search was conducted using PubMed and Ovid MEDLINE with the keywords “digoxin” and “toxicity.” Clinical and laboratory features of toxicity were extracted and analyzed. Of the 2,399 articles identified, only 10 met the inclusion criteria for final review. In 4 of the 10 cases, diuretics were implicated as interacting medications. Commonly reported symptoms included nausea, vomiting, visual disturbances, bradycardia, and elevated serum digoxin levels. Identified risk factors for toxicity included female sex, advanced age (60–91 years), renal impairment, and concomitant drug use. Notably, toxicity was observed even at therapeutic or low serum digoxin concentrations in the presence of these risk factors. The most frequent clinical manifestations were gastrointestinal symptoms, vision changes, and bradycardia.
Journal of Applied Pharmaceutical Technologies and Systems
Review | Open access | 10 January 2022 | Article: 29

The Toxicology of Novichok Nerve Agents: Mechanisms, Manifestations, and Management
Nerve agents are among the most potent and widely recognized chemical weapons. Recently, a new class of nerve agents, known as Novichok, has emerged as both a hazardous and frequently utilized tool in terrorist attacks. Medical professionals must gain a comprehensive understanding of the fundamental chemical and pharmacological properties of Novichok agents. This article provides a detailed review of the history, development, chemical structure, mechanism of action, toxicokinetics, and toxicology of these agents. Additionally, it discusses the latest diagnostic and treatment approaches for poisoning caused by Novichok agents. Contrary to earlier beliefs, Novichok poisoning shares similarities with other organophosphate toxins and can be effectively managed with timely and appropriate treatment. Given the global threat posed by terrorist incidents involving these agents, medical teams need to be well-versed in their characteristics to ensure optimal diagnosis and care for affected individuals.
Journal of Applied Pharmaceutical Technologies and Systems
Review | Open access | 10 January 2022 | Article: 30

Progress in Chiral Stationary Phase Design for Enantioseparation: A Brief Review
Producing enantiomerically pure drugs from racemic mixtures has become a critical objective in modern pharmaceutical science. Racemic compounds typically consist of two or more enantiomers, of which only one may be therapeutically active, while the others may be biologically inactive or even toxic, including teratogenic effects. Hence, the ability to effectively isolate the desired enantiomer is essential for ensuring both the safety and effectiveness of pharmaceutical treatments. This mini-review provides an overview of recent innovations in chiral stationary phases (CSPs) employed for the resolution of racemic drugs and mixtures. It covers various classes of CSPs, including those based on Pirkle-type selectors, polysaccharides, polypeptides, inclusion complexes, ligand-exchange mechanisms, macrocyclic antibiotics, and other novel materials. The performance of these phases in a range of separation techniques—such as high-performance liquid chromatography (HPLC), gas chromatography (GC), capillary electrophoresis (CE), supercritical fluid chromatography (SFC), and simulated moving bed (SMB) chromatography—is examined. Emphasis is also placed on the types of molecular interactions between CSPs and target analytes that drive effective enantioseparation.
Journal of Applied Pharmaceutical Technologies and Systems
Review | Open access | 10 July 2022 | Article: 44
Filters
Clear All

Subject
Advanced Characterization of Bio-Nano Systems Advanced Drug Delivery Technologies Automation, Robotics and Digitalization in Pharmaceutical Manufacturing Bio-Nano Environmental Monitoring and Remediation Bio-Nano Interfaces and Interactions Bio-Nano Reproducibility, Standardization, Quality and Regulation Bio-Nano Systems Bio-Nano Technologies for Food, Agriculture and Industrial Biotechnology Bio-Nano Translation, Scale-up and Manufacturing Bio-enabled and Bio-inspired Nanoscale Materials Bioactive Scaffolds and Biomimetic Materials Biocompatibility, Biodistribution and Degradation Bioelectronics and Nano-Bioelectronics Biological Information Transfer and Bio-inspired Communication Systems Biologics Manufacturing Technologies Biomaterials Biopharmaceutical Processing and Manufacturing Biosensors, Nanosensors and Bioanalytical Platforms Clinical and Biomedical Technologies Computational Modeling and Simulation of Bio-Nano Systems Controlled, Targeted and Responsive Delivery Platforms Data and Reporting Standards Diagnostic and Therapeutic Applications Drug Delivery Systems Drug Formulation and Dosage-form Development Environmental Fate and Risk Evaluation of Bio-Nano Materials Good Manufacturing Practice (GMP) and Manufacturing Compliance Green Pharmaceutical Engineering and Resource Efficiency Green and Sustainable Synthesis of Nanomaterials Interdisciplinary Health Sciences Lab-on-chip and Micro/Nanofluidic Systems Lyophilization Machine Learning and Data-driven Methods for Bio-Nano Systems Medical and Dental Applications Modeling, Simulation and Computational Methods for Pharmaceutical Processes Molecular and Nanoscale Communication Nano-Bio Imaging and Contrast Agents Nano-enabled Biomedical Technologies Nano-enabled Drug Delivery Nanobiotechnology and Bionanotechnology Nanomaterials for Biomedical and Biological Applications Nanomedicine and Nano-enabled Therapeutic Systems Nanopharmaceuticals Nanotechnology Nanotechnology in Dentistry and Oral Health Nanotoxicology and Bio-Nano Safety Assessment Open Science Optical and Photonic Bio-Nano Systems Pharmaceutical Contamination Control Pharmaceutical Engineering Pharmaceutical Manufacturing Sustainability Pharmaceutical Manufacturing Systems Pharmaceutical Manufacturing Technologies Pharmaceutical Materials and Excipients Pharmaceutical Nanotechnology Pharmaceutical Packaging and Container-closure Systems Pharmaceutical Particle Engineering and Processing Pharmaceutical Process Development Pharmaceutical Process Monitoring and Real-time Quality Assurance Pharmaceutical Process Optimization Pharmaceutical Process Validation Pharmaceutical Production Systems Pharmaceutical Production Technologies Pharmaceutical Quality Control and Quality Assurance Pharmaceutical Regulatory Science and Validation Studies Pharmaceutical Scale-up and Technology Transfer Pharmaceutical Stability, Storage and Cold Chain Pharmaceutical Supply, Distribution, Traceability and Serialization Pharmaceutical Technology Point-of-care Technologies Process Analytical Technology (PAT) Publication Ethics Quality and Production Technologies Quality by Design (QbD) and Design of Experiments Research Integrity Smart Materials with Nanoscale Structure or Function Sterile Manufacturing and Aseptic Processing Theranostics Tissue Engineering and Regenerative Medicine Translational Research Translational and Industrial Pharmaceutical Studies Wearable and Implantable Biointerfaces




Access type